Back
Spyre Therapeutics Stock Price Chart
Sponsored
SYRE
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
SYRE
Spyre Therapeutics
Last Price:
30.15
Seasonality Move:
-4.84%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Spyre Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.97 | Buy |
20-day SMA: | 28.07 | Buy |
50-day SMA: | 27.96 | Buy |
200-day SMA: | 29.09 | Buy |
8-day EMA: | 29.06 | Buy |
20-day EMA: | 28.34 | Buy |
50-day EMA: | 28.24 | Buy |
200-day EMA: | 27.28 | Buy |
Spyre Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.59 | Buy |
Relative Strength Index (14 RSI): | 60.55 | Buy |
Chaikin Money Flow: | 253932 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.52 - 29.08) | Buy |
Bollinger Bands (100): | (25.58 - 34.28) | Buy |
Spyre Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Spyre Therapeutics Stock
Is Spyre Therapeutics Stock a Buy?
- Spyre Therapeutics share price is 30.39 while SYRE 8-day simple moving average is 28.97, which is a Buy signal.
- The stock price of SYRE is 30.39 while Spyre Therapeutics 20-day SMA is 28.07, which makes it a Buy.
- Spyre Therapeutics 50-day simple moving average is 27.96 while SYRE share price is 30.39, making it a Buy technically.
- SYRE stock price is 30.39 and Spyre Therapeutics 200-day simple moving average is 29.09, creating a Buy signal.
SYRE Technical Analysis vs Fundamental Analysis
Buy
53
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy or a Sell?
-
Spyre Therapeutics stock is rated a Buy
The current Spyre Therapeutics [SYRE] share price is $30.39. The Score for SYRE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Spyre Therapeutics Stock Info
Market Cap:
1.54B
Price in USD:
30.39
Share Volume:
326.02K
Spyre Therapeutics 52-Week Range
52-Week High:
47.97
52-Week Low:
8.43
Buy
53
Spyre Therapeutics (SYRE)
is a Buy
Spyre Therapeutics Share Price Forecast
-
What is the Spyre Therapeutics stock price today?
The Spyre Therapeutics stock price is 30.39 USD today. -
Will SYRE stock go up or go down?
Spyre Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Spyre Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spyre Therapeutics is not overvalued.
Is Spyre Therapeutics Stock a Buy?
- Spyre Therapeutics share price is 30.39 while SYRE 8-day exponential moving average is 29.06, which is a Buy signal.
- The stock price of SYRE is 30.39 while Spyre Therapeutics 20-day EMA is 28.34, which makes it a Buy.
- Spyre Therapeutics 50-day exponential moving average is 28.24 while SYRE share price is 30.39, making it a Buy technically.
- SYRE stock price is 30.39 and Spyre Therapeutics 200-day simple moving average is 27.28, creating a Buy signal.
Fundamental Analysis of Spyre Therapeutics
Is Spyre Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.24 per share, an increase this year of $9.51 per share, and an increase next year of $0.02 per share.
Technical Analysis of Spyre Therapeutics
Should I short Spyre Therapeutics stock?
- SYRE Moving Average Covergence Divergence (MACD) indicator is 0.59, suggesting Spyre Therapeutics is a Buy
- Spyre Therapeutics Relative Strength Index (RSI) is 60.55, which suggest Spyre Therapeutics is overbought
- The Bollinger Bands (25) for Spyre Therapeutics is (26.52 - 29.08), which suggest Spyre Therapeutics is a Buy
- The Bollinger Bands (100) for Spyre Therapeutics is (25.58 - 34.28), which suggest Spyre Therapeutics is a Buy
* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.